Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$5.7M
4 rounds on record
Latest round
$4M
Venture round · Jul 2024 · 2 yr ago
Team
1
US Form 5500 (plan participants) · Dec 2025
Backers
1
Human Ventures
The money's age
Long since its last round
25 months since the last round · not hiring
Momentum
0/100
no fresh signals
Funding rounds
RoundDateAmountInvestorsSource
Venture round Jul 2024 $4M — SEC Form D
Venture round Mar 2023 $131k — SEC Form D
Venture round Aug 2021 $545k — SEC Form D
Venture round Jan 2018 $1M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Mimikai, Inc. sec
Founders and leadersfrom filings, registers and the company's site
Damon GorrieDirectorSEC Form D
Stephanie WatsonExecutive Officer, DirectorSEC Form D
Michelle ArnauExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs

Overview

Mimikai is the first new EPA-registered insect repellent in over 25 years, powered by Undecanone — a naturally occurring compound from wild tomato plants. DEET-free, plant-based, and scientifically proven to protect against mosquitoes for up to 8 hours and ticks for up to 4 hours.

People

Damon Gorrie
Director
Stephanie Watson
Executive Officer, Director
Michelle Arnau
Executive Officer, Director
Frank Lin
Director
Martin Mulvihill
Director
Stephanie Sarelakos
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Los Angeles United States
HQ
10-50 est. staff

Financials

Total raised
$5.7M
Latest round
Venture - Series Unknown
Funding rounds
4
Funding rounds
Round Announced Amount
Venture - Series Unknown 2024 $4M Details
Venture - Series Unknown 2023 $131k Details
Venture - Series Unknown 2021 $545k Details
Venture - Series Unknown 2018 $1M Details